1887

oa SA Pharmaceutical Journal - Pharmacovigilance - who is responsible and why should we care? : forum

Volume 77, Issue 9
  • ISSN : 2221-5875

 

Abstract

The World Health Organisation defines as "the science and activities related to the detection, assessment, understanding and prevention of Adverse Drug Reactions (ADR) and drug-related problems". With respect to pharmacovigilance, both sound clinical judgement of the adverse drug reaction (ADR) and insight into the effects of the drug are required to allow a conclusion to be drawn as to the relationship between the adverse event and the drug involved. Pharmacovigilance is a responsibility shared by manufacturers, drug regulators, public health programmes, clinical institutions, academic researchers, health care workers, the media and consumers alike.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/mp_sapj/77/9/EJC82473
2010-10-01
2017-03-23

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error